Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 6 of the 13 calendar months from Oct 2025 to Oct 2026: Oct 2025, Nov 2025, Feb 2026, Mar 2026, May 2026 and Aug 2026.
- Largest single sale: $1.5M (48,945 shares) of Arcutis Biotherapeutics, Inc. on Nov 24, 2025. Filing
- Last sale before this period: Oct 2, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: President and Chief Executive Officer, Director | Jan 30, 2020 | Aug 5, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 3, 2026, Arcutis Biotherapeutics, Inc.: sold 4,375 shares for $114K, under a disclosed plan. 1 filing: 1
- May 4, 2026, Arcutis Biotherapeutics, Inc.: sold 3,172 shares for $75K, under a disclosed plan. 1 filing: 1
- Mar 2, 2026, Arcutis Biotherapeutics, Inc.: sold 37,349 shares for $941K, under a disclosed plan. 1 filing: 1
- Feb 27, 2026, Arcutis Biotherapeutics, Inc.: 102,000 shares granted. 1 filing: 1
- Feb 2, 2026, Arcutis Biotherapeutics, Inc.: sold 19,833 shares for $506K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.